ADXN
Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
ADXN fundamentals
Addex Therapeutics (ADXN) released its earnings on Dec 4, 2025: revenue was 62.26K (YoY -2.34%), beat estimates; EPS was -0.012553 (YoY +47.00%), missed estimates.
Revenue / YoY
62.26K
-2.34%
EPS / YoY
-0.012553
+47.00%
Report date
Dec 4, 2025
ADXN Earnings Call Summary for Q3,2025
- GABAB PAM for Cough: IND-enabling studies ready; potential best-in-class efficacy with 70% cough reduction in preclinical models.
- Dipraglurant Repositioning: Fast onset, short half-life; clinical studies preparation with Lund University/Sinntaxis.
- Stalicla Progress: Autism patient stratification studies advancing; mavoglurant out-licensing and Series C financing in pipeline.
- Financial Sustainability: CHF 2.2 million cash runway; external funding needed for unpartnered programs.
- Competitive Insights: CCR5 modulators in stroke recovery trials (e.g., maraviroc) provide learnings for adaptive rewiring mechanisms.
- Indivior Milestones: Up to USD 330 million in potential payments; royalty rates 5-10% on net sales.
EPS
Revenue
Revenue & Expenses
ADXN has released its 2025 Q3 earnings report, with revenue of 62.26K, reflecting a YoY change of -9.89%, and net profit of -1.98M, showing a YoY change of -9.27%. The Sankey diagram below clearly presents ADXN's revenue sources and cost distribution.
Key Indicators
Addex Therapeutics (ADXN) key financial stats and ratios, covering profitability, financial health, and leverage.
Addex Therapeutics (ADXN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Addex Therapeutics (ADXN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Addex Therapeutics (ADXN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Addex Therapeutics (ADXN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Addex Therapeutics (ADXN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Addex Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Addex Therapeutics’s earnings call?What is Addex Therapeutics's gross profit margin?What is the market's earnings forecast for Addex Therapeutics next quarter?What factors drove the changes in Addex Therapeutics's revenue and profit?What does Addex Therapeutics do and what are its main business segments?What were the key takeaways from Addex Therapeutics's earnings call?Did Addex Therapeutics beat or miss consensus estimates last quarter?
